Certain HIF-1 inhibitors, such as PX-478, PMX290, and FK228, have demonstrated the ability to enhance the antitumor effects of chemotherapy and radiotherapy by inducing apoptosis in pancreatic ductal adenocarcinoma and various other cancers (Bui et al., 2022). Here, HIF1A is linked to cancer.